drugset / Trial / NCT02935608

Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy

NCT02935608

Phase 2 Completed 502 enrolled Biogen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study is to evaluate the efficacy of two dose regimens of BIIB074 on neuropathic pain in participants with pain from lumbosacral radiculopathy (PLSR). Secondary objectives are to evaluate the efficacy of 2 dose regimens of BIIB074 on additional neuropathic pain measures and assessments of low back pain, disability, and quality of life; To investigate the safety and tolerability of 2 dose regimens of BIIB074 and To characterize the pharmacokinetics (PK) of BIIB074 in this population.

Timeline

Start
2016-10-31
Primary completion
2018-08-06
Completion
2018-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Vixotrigine Small molecule

Indications